Equity

Corporate News

Gland Pharma to acquire Gland Pharma USA Inc. for USD 5,001,208 by October 2026
(13-Sep-2026, 16:59 Hours IST)  

Gland Pharma Limited announced that its board approved the acquisition of 100% of the equity share capital of Gland Pharma USA Inc. ("Gland US") from Gland Pharma International Pte. Ltd., for a cash consideration of USD 5,001,208. The acquisition, expected to be completed by October 31, 2026, will make Gland US a direct wholly-owned subsidiary of Gland Pharma Limited, streamlining the corporate structure and removing multiple layers. Gland US, incorporated in March 2022, is involved in the marketing and distribution of pharmaceutical products and had a turnover of USD 87,342 for the fiscal year ending March 31, 2025, and USD 4,83,808 for the fiscal year ending March 31, 2024.

Friday, September 11, 2026 12:00:00 AM
Adani Ports1765.00comprofit(0.42)%
      
Asian Paints2470.00comprofit(-0.40)%
      
Axis Bank1247.50comprofit(-0.99)%
      
Bajaj Finance1034.20comprofit(-1.13)%
      
Bajaj Finserv1917.30comprofit(-0.35)%
      
Bharat Electro..405.50comprofit(0.62)%
      
Bharti Airtel1832.00comprofit(-0.27)%
      
Eternal323.00comprofit(0.78)%
      
HCL Technologi..1207.00comprofit(0.85)%
      
HDFC Bank708.00comprofit(2.02)%
      
Hind. Unilever1934.00comprofit(-0.18)%
      
ICICI Bank1379.15comprofit(-0.35)%
      
Infosys1038.20comprofit(0.64)%
      
Interglobe Avi..4974.00comprofit(0.10)%
      
ITC260.25comprofit(0.48)%
      
Kotak Mah. Ban..418.70comprofit(0.42)%
      
Larsen & Toubr..3915.00comprofit(-1.01)%
      
M & M3120.00comprofit(-0.94)%
      
Maruti Suzuki12410.00comprofit(-0.96)%
      
NTPC333.30comprofit(-1.10)%
      
Power Grid Cor..269.10comprofit(-1.07)%
      
Reliance Indus..1258.00comprofit(-1.33)%
      
SBI997.00comprofit(-0.75)%
      
Sun Pharma.Ind..1842.00comprofit(-1.18)%
      
Tata Steel182.85comprofit(-1.67)%
      
TCS2202.00comprofit(-0.65)%
      
Tech Mahindra1539.50comprofit(1.38)%
      
Titan Company5005.00comprofit(-0.10)%
      
Trent2804.40comprofit(0.53)%
      
UltraTech Cem.10996.00comprofit(-0.52)%
      

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)